运用德尔菲法构建上市中药企业竞争力评价指标体系

摘要

目的 构建上市中药企业竞争力评价指标体系,为评价我国上市中药企业竞争力提供有效的技术和手段.方法 通过文献研究初步得到指标库,然后采用德尔菲法进行咨询,请20名相关领域资深专家依据各指标重要性打分,筛选上市中药企业竞争力评价指标体系维度及指标池,经过2轮问卷咨询,最终形成指标体系.结果第1、2轮问卷咨询的专家积极系数分别为95%、100%,专家权威程度为0.713 2,专家协调系数分别为0.659、0.639,指标体系最终包含5个1级指标、26个2级指标.结论 本次德尔菲法专家积极系数及权威程度均较高,第2轮咨询专家的意见已趋于一致,形成的上市中药企业竞争力评价指标体系结果可信.%Objective To construct the competitiveness evaluation index system of listed TCM pharmaceutical companies and provide efficient technology and methods for the evaluation in related field.Methods Index base was founded by the means of the literature research method at first. Then 20 experts were asked to score all these indexes according to the importance of each index. Dimensionality and index base of competitiveness evaluation index system of listed TCM pharmaceutical companies were screened. With two rounds of questionnaires, the evaluation index system was constructed finally.Results The positive coefficients of two rounds of expert consultation were 95% and 100%;the cooperative coefficients were 0.659 and 0.639;the authoritative coefficient was 0.713 2. Evaluation system consisted of 5 first grade indexes and 26 second grade indexes.Conclusion The positive coefficients and the authoritative coefficients are both high enough through Delphi method. Opinions of all the experts in the two round of expert consultation tend to be uniform, which reveals that the evaluation index system of listed TCM pharmaceutical companies is relatively scientific.